Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-21
1993-07-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 546153, 546155, 546175, 546176, A61K 3147, C07D21514
Patent
active
052311031
ABSTRACT:
The novel quinolin-2-yl-methoxybenzylhydroxyureas can be prepared by reaction of appropriate ketones with hydroxylamine and reduction of the ketoximes and subsequent reaction with isocyanates. The new substances can be employed as active substances in medicaments.
REFERENCES:
patent: 5091392 (1992-02-01), Raddatz et al.
Beilstein 4(3), p. 1861 (1949).
Beilstein 12, pp. 437-446.
C. King, J. Org. Chem., 1960, pp. 352-356.
Franz Effenberger, Chem. Ber., 1964, pp. 1576-1583.
Dr. H. Ulrich, Angewandte Chemie, Aug. 21, 1966, pp. 761-788.
CAS 38 459-58-4.
Gunther E. Jeromin, Chem. Ber., 1987, pp. 649-651.
Pierre Borgeat, Proc. Nat. Acad. Sci USA, May 1979, pp. 2148-2152.
Houben-Weyl VIII, 1952, p. 128.
Fruchtmann Romanis
Hatzelmann Armin
Kohlsdorfer Christian
Matzke Michael
Mohrs Klaus-Helmut
Bayer Aktiengesellschaft
Ivy C. Warren
Turnipseed James H.
LandOfFree
Quinolin-2-yl-methoxybenzylhydroxyureas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolin-2-yl-methoxybenzylhydroxyureas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolin-2-yl-methoxybenzylhydroxyureas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342517